Aster DM Healthcare [ASTERDM] vs Pfizer [PFIZER] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Aster DM Healthcare Ltd. wins in 7 metrics, Pfizer Ltd. wins in 13 metrics, with 0 ties. Pfizer Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Aster DM Healthcare Ltd. | Pfizer Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 110.37 | 25.56 | Pfizer Ltd. |
| Price-to-Book Ratio | 8.03 | 5.66 | Pfizer Ltd. |
| Debt-to-Equity Ratio | 43.79 | 2.33 | Pfizer Ltd. |
| PEG Ratio | -2.33 | 2.28 | Pfizer Ltd. |
| EV/EBITDA | 46.61 | 22.48 | Pfizer Ltd. |
| Profit Margin (TTM) | 7.33% | 34.39% | Pfizer Ltd. |
| Operating Margin (TTM) | 12.11% | 33.17% | Pfizer Ltd. |
| EBITDA Margin (TTM) | 12.11% | 33.17% | Pfizer Ltd. |
| Return on Equity | 147.28% | 18.20% | Aster DM Healthcare Ltd. |
| Return on Assets (TTM) | 81.40% | 15.63% | Aster DM Healthcare Ltd. |
| Free Cash Flow (TTM) | $683.20M | $6.32B | Pfizer Ltd. |
| Dividend Yield | 1.05% | 1.27% | Pfizer Ltd. |
| 1-Year Return | 43.05% | -23.35% | Aster DM Healthcare Ltd. |
| Price-to-Sales Ratio (TTM) | 8.17 | 8.78 | Aster DM Healthcare Ltd. |
| Enterprise Value | $373.17B | $194.17B | Aster DM Healthcare Ltd. |
| EV/Revenue Ratio | 8.37 | 7.82 | Pfizer Ltd. |
| Gross Profit Margin (TTM) | 77.44% | 65.15% | Aster DM Healthcare Ltd. |
| Revenue per Share (TTM) | $87 | $543 | Pfizer Ltd. |
| Earnings per Share (Diluted) | $6.39 | $186.40 | Pfizer Ltd. |
| Beta (Stock Volatility) | -0.06 | 0.17 | Aster DM Healthcare Ltd. |
Aster DM Healthcare Ltd. vs Pfizer Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Aster DM Healthcare Ltd. | -3.47% | 2.68% | 4.39% | 21.18% | 27.32% | 29.67% |
| Pfizer Ltd. | 0.20% | -0.22% | -8.81% | -4.87% | -9.94% | -8.09% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Aster DM Healthcare Ltd. | 43.05% | 181.55% | 407.76% | 372.16% | 372.16% | 372.16% |
| Pfizer Ltd. | -23.35% | 16.94% | -16.55% | 139.64% | 232.33% | 479.18% |
Performance & Financial Health Analysis: Aster DM Healthcare Ltd. vs Pfizer Ltd.
| Metric | ASTERDM | PFIZER |
|---|---|---|
| Market Information | ||
| Market Cap | ₹364.57B | ₹218.82B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 556,447 | 14,470 |
| 90 Day Avg. Volume | 656,240 | 18,450 |
| Last Close | ₹786.70 | ₹4,518.00 |
| 52 Week Range | ₹519.10 - ₹836.50 | ₹4,396.70 - ₹5,993.00 |
| % from 52W High | -5.95% | -24.61% |
| All-Time High | ₹836.50 (Jun 12, 2026) | ₹6,451.15 (Sep 02, 2024) |
| % from All-Time High | -5.95% | -29.97% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.20% |
| Quarterly Earnings Growth | -0.08% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.34% |
| Operating Margin (TTM) | 0.12% | 0.33% |
| Return on Equity (TTM) | 1.47% | 0.18% |
| Debt to Equity (MRQ) | 43.79 | 2.33 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹87.77 | ₹841.24 |
| Cash per Share (MRQ) | ₹24.81 | ₹591.12 |
| Operating Cash Flow (TTM) | ₹54.10B | ₹9.08B |
| Levered Free Cash Flow (TTM) | ₹53.78B | ₹7.68B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.05% | 1.27% |
| Last 12-Month Dividend | ₹6.00 | ₹70.00 |
Valuation & Enterprise Metrics Analysis: Aster DM Healthcare Ltd. vs Pfizer Ltd.
| Metric | ASTERDM (Apr 26, 2026) | PFIZER (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 110.37 | 25.56 |
| Forward P/E | 60.80 | 25.15 |
| PEG Ratio | -2.33 | 2.28 |
| Price to Sales (TTM) | 8.17 | 8.78 |
| Price to Book (MRQ) | 8.03 | 5.66 |
| Market Capitalization | ||
| Market Capitalization | ₹364.57B | ₹218.82B |
| Enterprise Value | ₹373.17B | ₹194.17B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.37 | 7.82 |
| Enterprise to EBITDA | 46.61 | 22.48 |
| Risk & Other Metrics | ||
| Beta | -0.06 | 0.17 |
| Book Value per Share (MRQ) | ₹87.77 | ₹841.24 |
Financial Statements Comparison: Aster DM Healthcare Ltd. vs Pfizer Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ASTERDM (2025) | PFIZER (2025) |
|---|---|---|
| Revenue/Sales | 40.69B | 22.81B |
| Cost of Goods Sold | 9.38B | 8.13B |
| COGS % of Revenue | 23.1% | 35.6% |
| Gross Profit | 31.31B | 14.68B |
| Gross Margin | 76.9% | 64.4% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 5.25B | 6.81B |
| Operating Margin | 12.9% | 29.9% |
| EBITDA | 8.75B | 9.13B |
| EBITDA Margin | 21.5% | 40.0% |
| Pre-Tax Income | 4.71B | 10.16B |
| Pre-Tax Income % of Revenue | 11.6% | 44.5% |
| Income Tax | 1.34B | 2.48B |
| Income Tax % of Revenue | 3.3% | 10.9% |
| Net Income (Profit) | 54.08B | 7.68B |
| Profit Margin | 132.9% | 33.7% |
Balance Sheet & Liquidity Metrics
| Metric | ASTERDM (2025) | PFIZER (2025) |
|---|---|---|
| Cash & Equivalents | 1.65B | 4.95B |
| Total Current Assets | 19.01B | 35.13B |
| Total Current Assets % of Revenue | 46.7% | 154.0% |
| Total Current Liabilities | 8.79B | 5.70B |
| Total Current Liabilities % of Revenue | 21.6% | 25.0% |
| Long-Term Debt | 18.29B | 676.20M |
| Long-Term Debt % of Revenue | 45.0% | 3.0% |
| Total Shareholders Equity | 36.51B | 42.17B |
| Retained Earnings | -1.52B | 24.36B |
| Retained Earnings % of Revenue | -3.7% | 106.8% |
| Property, Plant & Equipment | 12.75B | 1.72B |
Cash Flow Statement Comparison
| Metric | ASTERDM (2025) | PFIZER (2025) |
|---|---|---|
| Operating Cash Flow | 54.10B | 9.08B |
| Operating Cash Flow % of Revenue | 132.9% | 39.8% |
| Capital Expenditures | -3.44B | 1.24B |
| Free Cash Flow | 683.20M | 6.32B |
| FCF Margin | 1.7% | 27.7% |
| Debt Repayment | -1.34B | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASTERDM | PFIZER |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 516.94M | 45.75M |
| Float Shares | 191.44M | 15.10M |
| % Held by Insiders | 53.34% | 66.98% |
| % Held by Institutions | 31.94% | 16.80% |
| % Held by Public | 14.72% | 16.22% |
Dividend Analysis & Yield Comparison: Aster DM Healthcare Ltd. vs Pfizer Ltd.
| Metric | ASTERDM | PFIZER |
|---|---|---|
| Last 12-Month Dividend | ₹6.00 | ₹70.00 |
| Last 12-Month Dividend Yield | 1.05% | 1.27% |
| 3-Year Avg Annual Dividend | ₹41.33 | ₹46.67 |
| 3-Year Avg Dividend Yield | 11.45% | 0.58% |
| 3-Year Total Dividends | ₹124.00 | ₹140.00 |
| Ex-Dividend Date | Feb 10, 2025 | Jul 09, 2025 |